|
|
Volumn 822, Issue 1-2, 2005, Pages 294-299
|
|
Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma
a
|
|
Author keywords
Aripiprazole; LC MS MS; OPC 14857
|
|
Indexed keywords
BODY FLUIDS;
LINEAR EQUATIONS;
MASS SPECTROMETRY;
MATHEMATICAL MODELS;
METABOLITES;
REGRESSION ANALYSIS;
SEPARATION;
CHROMATOGRAPHIC SEPARATION;
LINEAR REGRESSION MODELS;
LOWER LIMIT OF QUANTITATION (LLOQ);
TANDEM MASS SPECTROMETRY;
LIQUID CHROMATOGRAPHY;
ARIPIPRAZOLE;
DEHYDROARIPIPRAZOLE;
DRUG METABOLITE;
OPC 14857;
UNCLASSIFIED DRUG;
ACCURACY;
ARTICLE;
ASSAY;
CALIBRATION;
CHROMATOGRAPHY;
COLUMN CHROMATOGRAPHY;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
HUMAN;
LINEAR REGRESSION ANALYSIS;
LIQUID CHROMATOGRAPHY;
PLASMA;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
QUANTITATIVE ASSAY;
REPRODUCIBILITY;
REVERSED PHASE LIQUID CHROMATOGRAPHY;
SEPARATION TECHNIQUE;
STATISTICAL MODEL;
TANDEM MASS SPECTROMETRY;
TIME;
VALIDATION PROCESS;
CHROMATOGRAPHY, LIQUID;
DRUG STABILITY;
HUMANS;
MASS SPECTROMETRY;
PIPERAZINES;
QUINOLONES;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 22244478615
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2005.06.023 Document Type: Article |
|
Times cited : (98)
|
|
References (3)
|
